MetaCap

iRadimed Earnings

NASDAQ: IRMDHealth CareMedical/Dental InstrumentsUSD

87.45+1.57 (+1.83%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Next earnings date

Mon, Nov 2, 2026

Fiscal period

Sep/2026

EPS estimate

$0.52

iRadimed earnings summary

iRadimed is scheduled to report Sep/2026 earnings on Nov 2, 2026, with analysts expecting EPS of $0.52. In its most recent report on Jul 31, 2026 (Q2 2026), IRMD posted EPS of $0.41. Revenue for the quarter was $20.5 million.

Quarterly EPS is down 8.9% from the same quarter a year earlier. Across the last 16 reports, IRMD shares moved an average of 4.1% (in either direction) in the first trading session after results, rising 10 times and falling 6 times.

Summary generated from market data by MetaCap's automated system. Methodology

IRMD earnings history

iRadimed reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Jul 31, 2026—$0.41—+1.8%
May 1, 2026—$0.45—-1.0%
Feb 10, 2026—$0.50—+3.8%
Nov 3, 2025—$0.43—+0.0%
Aug 1, 2025—$0.45—+5.7%
May 5, 2025—$0.37—+4.0%
Jan 10, 2025—$0.40—+4.6%
Oct 31, 2024—$0.40—+16.9%
Aug 1, 2024—$0.38—+0.1%
May 2, 2024—$0.32—-2.5%
Feb 8, 2024—$0.35—+4.9%
Nov 3, 2023—$0.40—-12.2%
Aug 3, 2023—$0.33—-1.8%
May 4, 2023—$0.27—-1.2%
Mar 2, 2023—$0.29—-2.0%
Nov 3, 2022—$0.27—+3.6%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related